Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V) (Q24188006)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25391139%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

1 reference

title

Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25391139%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

glycogen storage disease

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25391139%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Benedikt Schoser

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25391139%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Rosaline Quinlivan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25391139%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

12 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25391139%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25391139%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25391139%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

CD003458

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25391139%20AND%20SRC:MED&resulttype=core&format=json

Effect of oral sucrose shortly before exercise on work capacity in McArdle disease

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Oral branched-chain amino acids do not improve exercise capacity in McArdle disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

The effect of oral sucrose on exercise tolerance in patients with McArdle's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Effect of changes in fat availability on exercise capacity in McArdle disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Treatment of glycogenosis type V with ketogenic diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Exercise to exhaustion in the second-wind phase of exercise in a case of McArdle's disease with and without creatine supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Gentamicin treatment in McArdle disease: Failure to correct myophosphorylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Psychophysical bases of perceived exertion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

The I allele of the ACE gene is associated with improved exercise capacity in women with McArdle disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Molecular diagnosis of McArdle disease: revised genomic structure of the myophosphorylase gene and identification of a novel mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Phenotype modulators in myophosphorylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Fat metabolism during exercise in patients with McArdle disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

A metabolic myopathy due to absence of muscle phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Physical training for McArdle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Genotype modulators of clinical severity in McArdle disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Chronic progressive myopathy with myoglobinuria: demonstration of a glycogenolytic defect in the muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Long-term creatine intake is beneficial to muscle performance during resistance training.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Pharmacological and nutritional treatment for McArdle's disease (Glycogen Storage Disease type V)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

Effect of vitamin B6 supplementation in McArdle's disease: a strategic case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

McArdle's disease: a nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

McArdle's disease: Molecular genetics and metabolic consequences of the phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

The 577X allele of the ACTN3 gene is associated with improved exercise capacity in women with McArdle’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

McArdle disease: molecular genetic update

21 January 2018

1 reference

12 December 2020

Treatment of glycogenosys type V (McArdle disease) with creatine and ketogenic diet with clinical scores and with 31P-MRS on working leg muscle

1 reference

12 December 2020

A double blind, placebo controlled, crossover trial of D-ribose in McArdle's disease

1 reference

12 December 2020

Chronic therapy for McArdle disease: the randomized trial with ACE inhibitor

1 reference

12 December 2020

A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies

1 reference

12 December 2020

Improved energy kinetics following high protein diet in McArdle's syndrome. A 31P magnetic resonance spectroscopy study

1 reference

12 December 2020

Beneficial effects of dantrolene sodium in exercise-induced muscle pains: calcium mediated?

1 reference

12 December 2020

A comparative study on glucagon effect between mcardle disease and tarui disease

1 reference

12 December 2020

A FUNCTIONAL DISORDER OF MUSCLE ASSOCIATED WITH THE ABSENCE OF PHOSPHORYLASE.

1 reference

12 December 2020

Depot-glucagon in the treatment of McArdle's disease

1 reference

12 December 2020

Are high-protein diets effective in McArdle's disease?

1 reference

12 December 2020

Impairment of muscle mitochondrial oxidative metabolism in McArdles's disease

1 reference

12 December 2020

Carbohydrate- and protein-rich diets in McArdle disease: effects on exercise capacity

1 reference

12 December 2020

Myopathy in McArdle's syndrome. Improvement with a high-protein diet

1 reference

12 December 2020

Why do patients with McArdle's disease have decreased exercise capacity?

1 reference

12 December 2020

Brief periods of occlusion and reperfusion increase skeletal muscle force output in humans

1 reference

12 December 2020

Low muscle levels of pyridoxine in McArdle's syndrome

1 reference

12 December 2020

Dantrolene sodium does influence the second-wind phenomenon in McArdle's disease. Electrophysiological evidence during exercise in a double-blind placebo-controlled, cross-over study in 5 patients

1 reference

12 December 2020

Muscle fatigue in McArdle's disease studied by 31P-NMR: effect of glucose infusion

1 reference

12 December 2020

McArdle's syndrome: the reaction to a fat-rich diet

1 reference

12 December 2020

McArdle's disease: successful symptomatic therapy by high dose oral administration of ribose

1 reference

12 December 2020

Metabolic basis of improved exercise tolerance: muscle phosphorylase deficiency after glucagon administration

1 reference

12 December 2020

A double-blind, placebo-controlled, crossover study of verapamil in exertional muscle pain

1 reference

12 December 2020

Myopathy due to a defect in muscle glycogen breakdown

1 reference

12 December 2020

Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial

1 reference

12 December 2020

Impairment of muscle mitochondrial oxidative metabolism in McArdle's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB5

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD003458.PUB5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25391139%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

1 reference